We are live on
!
Find out more
LS
Leelyn Smith Portfolio holdings
AUM
$822M
1-Year Est. Return
31.69%
This Fund
S&P 500
This Quarter
Est. Return
+16.11%
1 Year Est. Return
+31.69%
3 Year Est. Return
+77.34%
5 Year Est. Return
+91.98%
10 Year Est. Return
–
AUM
$243M
AUM Growth
+$55.2M
(+29%)
Cap. Flow
+$46.5M
Cap. Flow
% of AUM
19.17%
Top 10 Holdings %
Top 10 Hldgs %
43.97%
Holding
439
New
112
Increased
115
Reduced
72
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
3M
MMM
|
+$24.2M |
| 2 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$2.84M |
| 3 |
iShares MSCI USA Small-Cap Min Vol Factor ETF
SMMV
|
+$2.46M |
| 4 |
ExxonMobil
XOM
|
+$2.14M |
| 5 |
Vanguard Morningstar Mega Cap Growth ETF
MGK
|
+$1.48M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Clorox
CLX
|
+$2.22M |
| 2 |
Microsoft
MSFT
|
+$2.06M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.93M |
| 4 |
Blackrock
BLK
|
+$1.33M |
| 5 |
State Street Communication Services Select Sector SPDR ETF
XLC
|
+$634K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 9.37% |
| 2 | Consumer Discretionary | 6.6% |
| 3 | Industrials | 5.97% |
| 4 | Consumer Staples | 5.81% |
| 5 | Healthcare | 5.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Lowe's Companies
LOW
$121B
| $1.99M | 0.82% |
14,736
+1,601
| +12% | +$183K |
|
27
Walmart Inc
WMT
$836B
| $1.96M | 0.81% |
49,134
+3,582
| +8% | +$147K |
|
|
28
Bristol-Myers Squibb
BMY
$138B
| $1.9M | 0.78% |
920
-32,218
| -97% | -$1.93M |
|
29
iShares MSCI USA Momentum Factor ETF
MTUM
$24.5B
| $1.89M | 0.78% |
14,440
+3,176
| +28% | +$384K |
|
30
Honeywell
HON
$68.3B
| $1.88M | 0.78% |
13,809
+4,026
| +41% | +$533K |
|
31
Procter & Gamble
PG
$338B
| $1.88M | 0.78% |
15,742
-253
| -2% | -$29.5K |
|
32
Analog Devices
ADI
$181B
| $1.86M | 0.76% |
15,131
+1,662
| +12% | +$183K |
|
33
Walt Disney
DIS
$192B
| $1.78M | 0.74% |
16,015
+1,909
| +14% | +$211K |
|
34
Nike
NKE
$59.1B
| $1.76M | 0.73% |
17,996
+1,908
| +12% | +$176K |
|
35
Johnson & Johnson
JNJ
$658B
| $1.76M | 0.72% |
12,502
-94
| -0.7% | -$13.7K |
|
36
Dominion Energy
D
$58.7B
| $1.75M | 0.72% |
23,610
+93
| +0.4% | +$7.46K |
|
37
General Mills
GIS
$21.2B
| $1.67M | 0.69% |
27,139
+1,660
| +7% | +$100K |
|
38
PepsiCo
PEP
$194B
| $1.65M | 0.68% |
12,514
+3
| +0% | +$395 |
|
39
Comcast
CMCSA
$96.6B
| $1.65M | 0.68% |
42,324
+5,099
| +14% | +$194K |
|
40
Starbucks
SBUX
$121B
| $1.63M | 0.67% |
22,180
+2,532
| +13% | +$190K |
|
41
Boeing
BA
$167B
| $1.6M | 0.66% |
8,711
+8,144
| +1,436% | +$1.25M |
|
42
Coca-Cola
KO
$395B
| $1.47M | 0.61% |
32,951
-49
| -0.1% | -$2.26K |
|
43
Altria Group
MO
$113B
| $1.45M | 0.6% |
32,432
+1,086
| +3% | +$42.4K |
|
|
44
Microsoft
MSFT
$3.64T
| $1.45M | 0.6% |
7,103
-11,358
| -62% | -$2.06M |
|
45
Pfizer
PFE
$162B
| $1.43M | 0.59% |
46,166
+97
| +0.2% | +$3.29K |
|
46
General Dynamics
GD
$102B
| $1.41M | 0.58% |
9,414
+1,243
| +15% | +$176K |
|
47
T. Rowe Price
TROW
$23.9B
| $1.4M | 0.58% |
11,357
+221
| +2% | +$25.2K |
|
48
RTX Corp
RTX
$283B
| $1.37M | 0.57% |
22,309
+5,056
| +29% | +$316K |
|
49
AT&T
T
$176B
| $1.36M | 0.56% |
67,157
-4,512
| -6% | -$103K |
|
50
Southern Company
SO
$103B
| $1.31M | 0.54% |
25,352
-328
| -1% | -$18.2K |
|
Similar funds
SCM
SCP
GSWM
HVIA
MGAM
IA
WRPWM
RP
Leelyn Smith's Q2 2020 Portfolio in Review
As of Q2 2020, Leelyn Smith held 439 positions worth $243M, up 29% from $187M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Leelyn Smith deployed $46.5M of net new capital in Q2 2020, opening 112 new positions and adding to 115 existing holdings. Its largest new stake was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
By sector, the portfolio is most concentrated in Technology at 9.4% of assets, up from 8.3% a quarter earlier, followed by Consumer Discretionary and Industrials.
On the sell side, the largest reduction was Clorox, an estimated $2.22M trimmed.
- Leelyn Smith's largest Q2 2020 buy was First Trust NYSE Arca Biotechnology Index Fund: 1,814 shares worth $304K.
- Leelyn Smith added most to 3M in Q2 2020, an estimated $24.2M increase.
- Leelyn Smith's biggest Q2 2020 reduction was Clorox, cutting an estimated $2.22M.
- Leelyn Smith fully exited iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, selling an estimated $333K.
- Leelyn Smith's ten largest holdings make up 44% of its $243M portfolio in Q2 2020.
- Leelyn Smith opened 112 new positions and closed 39 in Q2 2020.
- Leelyn Smith's portfolio value rose 29% quarter-over-quarter to $243M.
Based on Leelyn Smith's 13F filing for Q2 2020, filed 6 Aug 2020.